Last reviewed · How we verify
NCT06572046
STOP-HSP.Net: a Registry for Hereditary Spastic Paraplegia as an Integration Tool for Future Therapeutic Strategies
trial in Hereditary Spastic Paraplegia in 500 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | IRCCS Fondazione Stella Maris |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 24 January 2024 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across Italy |
Conditions studied
- Hereditary Spastic Paraplegia — all drugs for Hereditary Spastic Paraplegia →
Sponsor
IRCCS Fondazione Stella Maris — full company profile →
Who can join
Eligibility, any sex, with Hereditary Spastic Paraplegia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our goal is to create a solid and harmonious disease registry of patient affected by hereditary spastic paraplegia (HSP) that facilitates the collection and management of patients' data over time encouraging the research and the development of future clinical trials. In-depth clinical phenotyping will develop significant clinical outcome measures that can be used in clinical trials and will allow the phenotypic complexity of the disease to be captured with the use of validated clinical scales, biomarkers and so-called patient reported outcomes (PROs).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06572046
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hereditary Spastic Paraplegia
Currently open trials in the same condition.
- NCT07478172 — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease · NA · recruiting
- NCT07417943 — Neuromodulation to Enhance Motor Function in HSP · NA · recruiting
- NCT06936163 — A Prospective Cohort Study of Surgical Treatment for Foot Deformities in HSP · recruiting
- NCT06844734 — A Prospective Cohort Study of ITB Treatment for HSP · recruiting
- NCT06478238 — Calcium Folinate Treatment of Spastic Paraplegia 56 · EARLY_PHASE1 · recruiting
Other IRCCS Fondazione Stella Maris trials
Trials by the same sponsor.
- NCT07207213 — SOCIAL: Adaptation and Validation of the In-person PEERS® Program for Adolescents With Autism. · NA · not yet recruiting
- NCT06797050 — A Story for Pepper & Nao · NA · recruiting
- NCT06826287 — 7T Anatomo-functional Characterization of Structures in the Action Observation Network · recruiting
- NCT06666829 — Multicenter Study That Offers New Solutions for Paediatric Rehabilitation by Proposing a Rehabilitation Plan Based on Ea · NA · recruiting
- NCT06817746 — Telehealth Intervention for Infants With Prodromes of ASD · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06572046 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IRCCS Fondazione Stella Maris
- Last refreshed: 27 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06572046.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing